Intravenous Catheters Market Analysis
The intravenous catheters industry by product type is categorized into midline peripheral catheter, peripherally inserted central catheter, and central venous catheter. The peripherally inserted central catheter segment held over USD 5.4 billion revenue in 2023.
- The versatility of PICCs makes them suitable for outpatient and homecare settings. The insertion of PICCs is generally less traumatic for patients compared to other central venous catheters. The catheter is typically inserted in the arm, avoiding sensitive areas like the neck or chest, which can improve patient comfort. Patients can receive intravenous therapy at home, which can enhance their quality of life and reduce the burden on healthcare facilities.
- Additionally, compared to traditional central venous catheters, PICCs have a lower risk of infection and other complications. Their insertion is typically less invasive, leading to a reduced risk of pneumothorax and other associated issues.
- Further, advances in medical imaging technologies, such as ultrasound guidance during catheter insertion, enhance the accuracy and safety of the procedure, making PICCs a more attractive option.
Based on gauge size, the intravenous catheters market is segmented into 14G – 16G, 17G – 18G, 19G – 20G, 21G – 22G, and 23G+. The 21G – 22G segment is anticipated to reach USD 5.9 billion by 2032.
- Catheters in the 21 – 22 gauge range are commonly used for routine IV infusions in both adults and pediatric patients. They provide a balanced compromise between flow rate and patient comfort. These catheters are suitable for administering medications that do not require a rapid flow rate. They are commonly used for a variety of medications in different healthcare settings.
- In pediatric patients, who often have smaller veins, 21 – 22 gauge catheters may be preferred to minimize discomfort and potential complications.
- Furthermore, for short-term intravenous therapy that does not require a large volume or rapid infusion, healthcare professionals may choose catheters in the 21 – 22 gauge range.
The intravenous catheters market by lumen is categorized into single lumen, double lumen, and multi-lumen. The single lumen segment accounted for USD 3.8 billion revenue size in 2023.
- Single-lumen catheters are frequently employed for routine intravenous infusions in hospitals, clinics, and outpatient settings. They provide a simple and effective means of delivering fluids, medications, or nutrients directly into the patient's bloodstream.
- Moreover, in situations where a patient requires a single medication, single-lumen catheters are commonly chosen for medication administration. This can include antibiotics, pain medications, and other intravenous drugs. For blood transfusions where only one type of blood product needs to be administered, single-lumen catheters are often utilized.
- Single-lumen catheters are commonly employed in pediatric patients, where the volume of fluid or medication needed may be smaller, and a single lumen is sufficient.
Based on material, the intravenous catheters market is segmented into polyurethane, silicone, PVC, and other materials. The silicone segment is expected to expand at a CAGR of 8.1% during the forecast period.
- Silicone is known for its biocompatibility, which means it is generally well-tolerated by the body. This property can be advantageous in reducing the risk of irritation or allergic reactions. Also, silicone catheters are often soft and flexible, making them more comfortable for patients. This characteristic can be particularly beneficial in situations where long-term catheterization is required.
- Silicone catheters have a higher resistance to kinking compared to other materials, contributing to the stability of the catheter during use. The softness and durability of silicone may make it a suitable choice for catheters intended for long-term use.
The intravenous catheters market by end-use is categorized into hospitals, ambulatory surgical centers, and other end-users. The hospitals segment recorded around USD 5.2 billion revenue size in 2023.
- Intravenous catheters are commonly used during surgical procedures to administer anesthesia, antibiotics, and other medications, as well as to provide intravenous fluids. IV catheters play a vital role in postoperative care by facilitating the administration of pain medications, fluids, and other necessary treatments. Majority of the surgical procedures are performed in hospital settings, thus due to increased product demand the segment is anticipated to witness robust growth.
- Intravenous catheters are crucial for administering blood transfusions in hospital settings, particularly in surgical and critical care units.
- Moreover, hospitals use intravenous catheters to provide parenteral nutrition to patients who are unable to receive adequate nutrition through oral or enteral routes.
North America intravenous catheters market size reached USD 3.1 billion in 2023 and is set to witness substantial industry growth over the analysis timeline.
- The trend toward home healthcare services in North America has led to increased demand for intravenous catheters suitable for use in a home setting. Patients receiving intravenous therapies at home may require distinct types of catheters.
- Additionally, the rise of ambulatory care centers and outpatient clinics also contributes to the demand for intravenous catheters. These settings often require catheters for a range of medical procedures and treatments. For example, according to a recently published article by Sg2, a Vizient company in its “2023 Impact of Change Forecast” stated that ambulatory surgery centers (ASCs) are expected to record double-digit growth over the next decade.
- Further, emphasis on patient safety and the reduction of healthcare-associated infections has led to the development and adoption of catheters with features such as antimicrobial coatings, potentially influencing demand. Such developments will further fuel the product demand in the region.